Is a complete TNGX research report available?

No complete published report is available for Tango Therapeutics, Inc. (TNGX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · USD

$25.9

-0.80 (-3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TNGX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.7B
Revenue (ttm)	57M
Net income (ttm)	-107.2M
EPS (ttm)	-$0.86
Shares out	144.6M
Volume	2,209,247
Beta	1.13
Price target	$44.3	+71.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57M
Net income (ttm): -107.2M
EPS (ttm): -$0.86
Market cap: 3.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TNGX indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001819133
Company name	Tango Therapeutics, Inc.
Country	United States
Country code	US
Cusip	87583X109
Employees	137
Employees Change	-18%
Employees Change Percent	-11.61
Enterprise value	$3.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US87583X1090
Last refreshed	2026-07-30
Market cap	$3.7B
Market cap category	Mid-Cap
Price	$25.85
Price currency	USD
Rev Per Employee	416,000x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	2834
Symbol	TNGX
Website	https://www.tangotx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.87%
EV Sales Forward	2,576.27x
EV/Sales	59.52x
FCF yield	-3.81%
P/B ratio	9.52x
P/S ratio	65.61x
PS Forward	2,839.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-206.22%
EBITDA Margin	-202.5%
Gross margin	-126.8%
Gross Profit	$-72.3M
Net Income	$-107.2M
Net Income Growth Years	1%
Pretax Margin	-188.2%
Profit Margin	-188.15%
Profit Per Employee	$-782,715
ROA	-20.69
Roa5y	-17.38
ROCE	-27.89
ROE	-38.42
Roe5y	-40.42
ROIC	-23.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	287.92%
Cagr3y	103.85%
Cagr5y	21.06%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	39.04x
Revenue Growth Years	3x
Revenue Growth3 Y	31.84x
Revenue Growth5 Y	43.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.16
Assets	$435.8M
Cash	$379.8M
Current Assets	$392.3M
Current Liabilities	$14.3M
Debt	$32.8M
Debt Equity	$0.08
Equity	$391.5M
Liabilities	$44.3M
Long Term Assets	$43.5M
Long Term Liabilities	$30M
Net Cash	$347.1M
Net Cash By Market Cap	$9.28
Net Cash Growth	93.04%
Net Debt Equity	$-0.89
Tangible Book Value	$391.5M
Tangible Book Value Per Share	$2.72
WACC	10.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	27.38
Net Working Capital	$990,000
Quick ratio	26.51
Working Capital	$378M
Working Capital Turnover	$0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	287.56%
200-day SMA	17.27
3Y total return	747.54%
50-day SMA	27.11
50-day SMA vs 200-day SMA	50over200
5Y total return	159.93%
All Time High	34.39
All Time High Change	-24.83%
All Time High Date	2026-06-17
All Time Low	1.03
All Time Low Change	2,409.71%
All Time Low Date	2025-05-08
ATR	1.84
Beta	1.13
Beta1y	0.77
Beta2y	1.21
Ch YTD	191.8
High	27.01
High52	34.39
High52 Date	2026-06-17
High52ch	-24.83%
Low	25.41
Low52	5.77
Low52 Date	2025-08-01
Low52ch	348.01%
Ma50ch	-4.65%
Premarket Change Percent	1.13
Premarket Price	$26.95
Premarket Volume	3,924
Price vs 200-day SMA	49.7%
RSI	41.42
RSI Monthly	69.66
RSI Weekly	59.22
Sharpe ratio	1.76x
Sortino ratio	3.66
Total Return	-13.42%
Tr YTD	191.8
Tr1m	-17.86%
Tr1w	-8.01%
Tr3m	2.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	11
Analyst Price Target Top	$42.36
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.32
Earnings Revenue Estimate	1,561,910x
Earnings Revenue Estimate Growth	-50.9x
Operating Income	$-117.5M
Operating margin	-206.2
Price target	$44.33
Price Target Change	$71.49
Price Target Change Top	$63.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,560,312%
Float Percent	48.09%
Shares Insiders	1.25%
Shares Institutions	76.61%
Shares Out	144,647,982
Shares Qo Q	9.11%
Shares Yo Y	13.42%
Short Float	61.41%
Short Ratio	9.28
Short Shares	29.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-172.5M
Adjusted OCF	-171,521,000
Average Volume	2,453,343.6x
Bv Per Share	2.72
CAPEX	$-997,000
Ch1m	-17.86
Ch1w	-8.01
Ch1y	287.6
Ch3m	2.82
Ch3y	747.5
Ch5y	159.9
Ch6m	131.2
Change	-3%
Change From Open	-3.62
Close	26.65
Days Gap	0.64
Depreciation Amortization	2,122,000
Dollar Volume	57,109,035
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-117.5M
EBITDA	$-115.4M
EPS	$-0.86
F Score	3
FCF	$-142.5M
FCF EV Yield	-4.2x
FCF Per Share	$-0.99
Financing CF	302,344,000
Fiscal Year End	December
Founded	2,014
Income Tax	$-29,000
Investing CF	-61,827,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	20.1
Ma150ch	28.59%
Ma20	28.65
Ma20ch	-9.76%
Net CF	98,968,000
Next Earnings Date	2026-08-11
Open	26.82
Optionable	Yes
Position In Range	27.5
Post Close	25.85
Postmarket Change Percent	-1.35
Postmarket Price	$25.5
Ppne	41,033,000
Pre Close	26.65
Price Date	2026-07-29
Ptbv Ratio	9.55
Relative Volume	0.9x
Revenue	56,992,000x
SBC By Revenue	52.59x
Share Based Comp	29,972,000
Tax By Revenue	-0.05x
Tr6m	131.22%
Us State	Massachusetts
Volume	2,209,247
Z Score	11.83

Tango Therapeutics, Inc. (TNGX)

Coverage state: Market snapshot only — no published research

Generate the first TNGX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TNGX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNGX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TNGX

Frequently asked questions